Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)? (Q91853647)
Jump to navigation
Jump to search
scientific article published on 20 March 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)? |
scientific article published on 20 March 2020 |
Statements
Is There a Role for Tissue Plasminogen Activator (tPA) as a Novel Treatment for Refractory COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)? (English)
Hunter B Moore
Christopher D Barrett
Ernest E Moore
Robert C McIntyre
Peter K Moore
Daniel S Talmor
Frederick A Moore
Identifiers
1 reference